CORT — CORCEPT THERAPEUTICS INC

Ownership history in Corient Private Wealth LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Corient Private Wealth LLC reported a position in CORCEPT THERAPEUTICS INC (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 6,435 +2,281 +54.9% 0.00% $535K $83.11
2025 Q2 ADDED 4,154 +40 +1.0% 0.00% $305K $73.40
2025 Q1 ADDED 4,114 +53 +1.3% 0.00% $470K $114.22
2024 Q4 INITIATED 4,061 — — 0.00% $205K $50.39
% of Fund (quarterly)    CORT price (monthly, adj. close)

Other funds also holding CORT

As of 2025 Q4 — sorted by position size

INGALLS & SNYDER LLC 3Y 7Y 9.19% TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 7.05% Checkpoint Capital L.P. 4.36% Parallel Advisors, LLC 3Y 7Y 2.47% Checkpoint Capital L.P. 1.39% Birchview Capital, LP 3Y 7Y 1.37% S&T BANK/PA 3Y 7Y 1.03% Intrinsic Edge Capital Management LLC 3Y 7Y 0.86% Newtyn Management, LLC 3Y 7Y 0.73% FAS Wealth Partners, Inc. 3Y 7Y 0.7%
← Back to Corient Private Wealth LLC Holdings